Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Early ART in primary HIV infection may also preserve lymphopoiesis capability in circulating haematopoietic progenitor cells: a case report.

Bordoni V, Casetti R, Viola D, Abbate I, Rozera G, Sacchi A, Cimini E, Tumino N, Agrati C, Orchi N, Pinnetti C, Ammassari A, Martini F.

J Antimicrob Chemother. 2015 May;70(5):1598-600. doi: 10.1093/jac/dku559. Epub 2015 Jan 20. No abstract available.

PMID:
25604747
2.

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics.

Ammassari A, Abbate I, Orchi N, Pinnetti C, Rozera G, Libertone R, Pierro P, Martini F, Puro V, Girardi E, Antinori A, Capobianchi MR.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19676. doi: 10.7448/IAS.17.4.19676. eCollection 2014.

3.

Evaluation in a clinical setting of the performances of a new rapid confirmatory assay for HIV1/2 serodiagnosis.

Abbate I, Pergola C, Pisciotta M, Sciamanna R, Sias C, Orchi N, Libertone R, Ippolito G, Capobianchi MR.

J Clin Virol. 2014 Sep;61(1):166-9. doi: 10.1016/j.jcv.2014.06.015. Epub 2014 Jun 24.

PMID:
25037532
4.

Antiretroviral treatment-based cost saving interventions may offset expenses for new patients and earlier treatment start.

Angeletti C, Pezzotti P, Antinori A, Mammone A, Navarra A, Orchi N, Lorenzini P, Mecozzi A, Ammassari A, Murachelli S, Ippolito G, Girardi E.

HIV Med. 2014 Mar;15(3):165-74. doi: 10.1111/hiv.12097. Epub 2013 Oct 31.

PMID:
24495188
5.

Early discharge of infectious disease patients: an opportunity or extra cost for the Italian Healthcare System?

Palmieri F, Alberici F, Deales A, Furneri G, Menichetti F, Orchi N, Quesada-Rodriguez C, Pilli S, Rapisarda F, Tassielli D, Tringali M, Esposito S, Ippolito G.

Infez Med. 2013 Dec;21(4):270-8.

6.

Temporal trend and characteristics of recent HIV-1 infections: application of an algorithm for the identification of recently acquired HIV-1 infections among newly diagnosed individuals over a 10-year period.

Orchi N, Sias C, Vlassi C, Navarra A, Angeletti C, Puro V, Sciarrone MR, Capobianchi MR, Girardi E.

New Microbiol. 2013 Oct;36(4):353-61. Epub 2013 Oct 1.

7.

The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis.

Scognamiglio P, Chiaradia G, De Carli G, Giuliani M, Mastroianni CM, Aviani Barbacci S, Buonomini AR, Grisetti S, Sampaolesi A, Corpolongo A, Orchi N, Puro V, Ippolito G, Girardi E; SENDIH Study Group.

BMC Infect Dis. 2013 Oct 10;13:473. doi: 10.1186/1471-2334-13-473.

8.

Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen.

Alteri C, Artese A, Beheydt G, Santoro MM, Costa G, Parrotta L, Bertoli A, Gori C, Orchi N, Girardi E, Antinori A, Alcaro S, d'Arminio Monforte A, Theys K, Vandamme AM, Ceccherini-Silberstein F, Svicher V, Perno CF.

J Antimicrob Chemother. 2013 Oct;68(10):2205-9. doi: 10.1093/jac/dkt173. Epub 2013 May 17.

9.

IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.

Vanini V, Petruccioli E, Gioia C, Cuzzi G, Orchi N, Rianda A, Alba L, Giancola ML, Conte A, Schininà V, Rizzi EB, Girardi E, Goletti D.

J Infect. 2012 Jul;65(1):49-59. doi: 10.1016/j.jinf.2012.03.017. Epub 2012 Mar 29.

PMID:
22465752
10.

HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy.

Mammone A, Pezzotti P, Angeletti C, Orchi N, Carboni A, Navarra A, Sciarrone MR, Sias C, Puro V, Guasticchi G, Ippolito G, Borgia P, Girardi E; SENDIH Study Group.

BMC Infect Dis. 2012 Mar 20;12:65. doi: 10.1186/1471-2334-12-65.

11.

'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing.

Alteri C, Santoro MM, Abbate I, Rozera G, Bruselles A, Bartolini B, Gori C, Forbici F, Orchi N, Tozzi V, Palamara G, Antinori A, Narciso P, Girardi E, Svicher V, Ceccherini-Silberstein F, Capobianchi MR, Perno CF.

J Antimicrob Chemother. 2011 Nov;66(11):2615-23. doi: 10.1093/jac/dkr354. Epub 2011 Sep 2.

12.

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.

Alteri C, Svicher V, Gori C, D'Arrigo R, Ciccozzi M, Ceccherini-Silberstein F, Selleri M, Bardacci SA, Giuliani M, Elia P, Scognamiglio P, Balzano R, Orchi N, Girardi E, Perno CF; SENDIH Study Group.

BMC Infect Dis. 2009 Jul 16;9:111. doi: 10.1186/1471-2334-9-111.

13.

Ageing with HIV: newly diagnosed older adults in Italy.

Orchi N, Balzano R, Scognamiglio P, Navarra A, De Carli G, Elia P, Grisetti S, Sampaolesi A, Giuliani M, De Filippis A, Puro V, Ippolito G, Girardi E; SENDIH group.

AIDS Care. 2008 Apr;20(4):419-25. doi: 10.1080/09540120701867073.

PMID:
18449818
14.

Effective highly active antiretroviral therapy in patients with primary HIV-1 infection prevents the evolution of the avidity of HIV-1-specific antibodies.

Selleri M, Orchi N, Zaniratti MS, Bellagamba R, Corpolongo A, Angeletti C, Ippolito G, Capobianchi MR, Girardi E.

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):145-50.

PMID:
17589369
15.

Consent policies and rates of HIV testing.

Girardi E, Puro V, De Carli G, Orchi N, Ippolito G.

JAMA. 2007 Jun 13;297(22):2478-9; author reply 2479. No abstract available.

PMID:
17565080
16.

Predisposition of antiretroviral prophylaxis for solid organ transplantation in human immunodeficiency virus-infected patients.

De Carli G, Puro V, Orchi N, Ippolito G.

Transpl Infect Dis. 2005 Sep-Dec;7(3-4):171-2. No abstract available.

PMID:
16390410
17.

HIV infection among low-risk first lifetime testers in Rome, 1990-2000.

Galati V, Serraino D, Puro V, Orchi N, De Carli G, Scognamiglio P, Nicastri E, Piselli P, Nurra G, Angeletti C, Girardi E, Ippolito G.

Infection. 2005 Apr;33(2):61-5.

PMID:
15827872
18.

Nonnucleoside reverse transcriptase inhibitor-containing regimens are associated with increased satisfaction with sexual life.

Murri R, Fantoni M, Del Borgo C, Longo B, Deiana G, Visonà R, Zambelli A, Barchi E, Orchi N, Bosco O, Wu AW.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):532-4. No abstract available.

PMID:
14657766
19.

Determinants of health-related quality of life in HIV-infected patients.

Murri R, Fantoni M, Del Borgo C, Visona R, Barracco A, Zambelli A, Testa L, Orchi N, Tozzi V, Bosco O, Wu AW.

AIDS Care. 2003 Aug;15(4):581-90.

PMID:
14509872
20.

Changing patterns of "hospital-at-home" care use by persons with AIDS in the era of combination antiretroviral therapy.

Orchi N, Girardi E, Antonucci G, Nurra G, Perucci CA, Ippolito G; Gruppo Romano per i Trattamenti a Domicilio.

AIDS Patient Care STDS. 2001 Dec;15(12):625-32.

PMID:
11788077
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk